TY  - CHAP
A1  - Kümmell, Steffen
A1  - Hillgärtner, Michael
T1  - Inductive charging comfortable and nonvisible charging stations for urbanised areas
T2  - E-Mobility in Europe : trends and good practice
N2  - For a wide acceptance of E-Mobility, a well-developed charging infrastructure is needed. Conductive charging stations, which are today’s state of the art, are of limited suitability for urbanised areas, since they cause a significant diversification in townscape. Furthermore, they might be destroyed by vandalism. Besides for those urbanistic reasons, inductive charging stations are a much more comfortable alternative, especially in urbanised areas. The usage of conductive charging stations requires more or less bulky charging cables. The handling of those standardised charging cables, especially during poor weather conditions, might cause inconvenience, such as dirty clothing etc. Wireless charging does not require visible and vandalism vulnerable charge sticks. No wired connection between charging station and vehicle is needed, which enable the placement below the surface of parking spaces or other points of interest. Inductive charging seems to be the optimal alternative for E-Mobility, as a high power transfer can be realised with a manageable technical and financial effort. For a well-accepted and working public charging infrastructure in urbanised areas it is essential that the infrastructure fits the vehicles’ needs. Hence, a well-adjusted standardisation of the charging infrastructure is essential. This is carried out by several IEC (International Electrotechnical Commission) and national standardisation committees. To ensure an optimised technical solution for future’s inductive charging infrastructures, several field tests had been carried out and are planned in near future.
KW  - E-mobility
KW  - Inductive charging
KW  - Charging stations
KW  - Urban areas
Y1  - 2015
SN  - 978-3-319-13193-1
U6  - http://dx.doi.org/10.1007/978-3-319-13194-8_16
SP  - 297
EP  - 309
PB  - Springer
CY  - Cham [u.a.]
ER  - 
TY  - CHAP
A1  - Niemueller, Tim
A1  - Reuter, Sebastian
A1  - Ewert, Daniel
A1  - Ferrein, Alexander
A1  - Jeschke, Sabina
A1  - Lakemeyer, Gerhard
T1  - Decisive Factors for the Success of the Carologistics RoboCup Team in the RoboCup Logistics League 2014
T2  - RoboCup 2014: Robot World Cup XVIII
Y1  - 2015
SN  - 978-3-319-18615-3
N1  - Lecture Notes in Computer Science ; 8992
SP  - 155
EP  - 167
PB  - Springer
ER  - 
TY  - CHAP
A1  - Digel, Ilya
A1  - Sadykov, R.
A1  - Temiz Artmann, Aysegül
A1  - Artmann, Gerhard
T1  - Changes in intestinal microflora in rats induced by oral exposure to low lead (II) concentrations
T2  - Lead Exposure and Poisoning: Clinical Symptoms, Medical Management and Preventive Strategies
Y1  - 2015
SN  - 9781634826990
SP  - 75
EP  - 99
PB  - Nova Science Publ.
ER  - 
TY  - CHAP
A1  - Kroll-Ludwigs, Kathrin
ED  - Colliess, Gralf-Peter
T1  - Art. 7 Rome III-Regulation (formal validity)
T2  - Rome Regulations :  commentary
Y1  - 2015
SN  - 9789041147547
PB  - Wolters Kluwer
ET  - 2nd ed.
ER  - 
TY  - CHAP
A1  - Calliess, Gralf-Peter
A1  - Kroll-Ludwigs, Kathrin
T1  - Art. 6 Rome III-Regulation (consent and material validity)
T2  - Rome Regulations : commentary
Y1  - 2015
SN  - 9789041147547
PB  - Wolters Kluwer
ER  - 
TY  - CHAP
A1  - Kroll-Ludwigs, Kathrin
ED  - Calliess, Gralf-Peter
T1  - Art. 5 Rom III-Regulation (choice of applicable law by the parties)
T2  - Rome Regulations : commentary
Y1  - 2015
SN  - 9789041147547
PB  - Wolters Kluwer
ET  - 2nd ed.
ER  - 
TY  - CHAP
A1  - Wolf, C. Roland
A1  - Kapelyukh, Yury
A1  - Scheer, Nico
A1  - Henderson, Colin J.
ED  - Wilson, Alan G. E.
T1  - Application of Humanised and Other Transgenic Models to Predict Human Responses to Drugs
N2  - The use of transgenic animal models has transformed our knowledge of complex biochemical pathways in vivo. It has allowed disease processes to be modelled and used in the development of new disease prevention and treatment strategies. They can also be used to define cell- and tissue-specific pathways of gene regulation. A further major application is in the area of preclinical development where such models can be used to define pathways of chemical toxicity, and the pathways that regulate drug disposition. One major application of this approach is the humanisation of mice for the proteins that control drug metabolism and disposition. Such models can have numerous applications in the development of drugs and in their more sophisticated use in the clinic.
Y1  - 2015
SN  - 978-1-78262-778-4
U6  - http://dx.doi.org/10.1039/9781782622376-00152
SP  - 152
EP  - 176
PB  - RSC Publ.
CY  - Cambridge
ER  -